Christopher W. Krueger - 13 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Business Officer
Signature
/s/ Christopher Krueger
Issuer symbol
VTYX
Transactions as of
13 Dec 2022
Net transactions value
-$1,033,668
Form type
4
Filing time
15 Dec 2022, 16:00:37 UTC
Previous filing
06 Dec 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $1,033,668 -30,000 -9.9% $34.46 272,692 13 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 30,000 shares sold in the price range of $34.10 to $34.82. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.